Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Anavex Life Sciences
AVXL
$273M
| $3.33M | ﹤0.01% |
+192,354
| New | +$3.65M |
|
|
MRO
2002
PUT
DELISTED
Marathon Oil Corporation
MRO
| $3.33M | ﹤0.01% |
202,800
+202,000
| +25,250% | +$3.25M |
|
|
UCTT
2003
Ultra Clean Holdings
UCTT
$4B
| $3.33M | ﹤0.01% |
58,027
-10,200
| -15% | -$531K |
|
2004
Brady Corp
BRC
$4.52B
| $3.33M | ﹤0.01% |
61,729
+11,127
| +22% | +$583K |
|
2005
RLJ Lodging Trust
RLJ
$1.87B
| $3.32M | ﹤0.01% |
238,637
+90,270
| +61% | +$1.27M |
|
2006
Sociedad Química y Minera de Chile
SQM
$19.1B
| $3.32M | ﹤0.01% |
65,815
+26,685
| +68% | +$1.53M |
|
2007
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
| $3.32M | ﹤0.01% |
61,518
-17,207
| -22% | -$970K |
|
|
MANT
2008
DELISTED
Mantech International Corp
MANT
| $3.31M | ﹤0.01% |
45,453
+11,282
| +33% | +$860K |
|
|
BBT
2009
Beacon Financial Corp
BBT
$2.69B
| $3.31M | ﹤0.01% |
116,516
+20,655
| +22% | +$572K |
|
2010
Center Bancorp
CNOB
$1.68B
| $3.31M | ﹤0.01% |
101,180
+16,362
| +19% | +$540K |
|
2011
Gibraltar Industries
ROCK
$1.37B
| $3.31M | ﹤0.01% |
49,577
+15,681
| +46% | +$1.12M |
|
2012
Edgewell Personal Care
EPC
$1.27B
| $3.31M | ﹤0.01% |
72,311
-11,794
| -14% | -$476K |
|
2013
CubeSmart
CUBE
$9.47B
| $3.3M | ﹤0.01% |
58,007
-93,631
| -62% | -$5.03M |
|
2014
ESCO Technologies
ESE
$8.24B
| $3.3M | ﹤0.01% |
36,621
+4,415
| +14% | +$382K |
|
|
MTOR
2015
DELISTED
MERITOR, Inc.
MTOR
| $3.29M | ﹤0.01% |
132,564
+15,126
| +13% | +$386K |
|
|
JWN
2016
CALL
DELISTED
Nordstrom
JWN
| $3.28M | ﹤0.01% |
145,000
+140,000
| +2,800% | +$3.71M |
|
|
FL
2017
CALL
DELISTED
Foot Locker
FL
| $3.27M | ﹤0.01% |
75,000
| – | – |
|
|
FL
2018
PUT
DELISTED
Foot Locker
FL
| $3.27M | ﹤0.01% |
75,000
| – | – |
|
2019
First Commonwealth Financial
FCF
$2.2B
| $3.27M | ﹤0.01% |
203,227
+59,113
| +41% | +$897K |
|
|
NATI
2020
DELISTED
National Instruments Corp
NATI
| $3.26M | ﹤0.01% |
74,761
-5,588
| -7% | -$238K |
|
2021
TechTarget
TTGT
$323M
| $3.26M | ﹤0.01% |
34,101
+8,079
| +31% | +$759K |
|
2022
PUT
Simon Property Group
SPG
$74.3B
| $3.26M | ﹤0.01% |
20,400
| – | – |
|
2023
United Therapeutics
UTHR
$25.7B
| $3.26M | ﹤0.01% |
15,070
-45,308
| -75% | -$8.89M |
|
2024
Manhattan Associates
MANH
$10.9B
| $3.25M | ﹤0.01% |
20,937
-53,023
| -72% | -$8.61M |
|
2025
Virtus Investment Partners
VRTS
$1.13B
| $3.25M | ﹤0.01% |
10,952
+3,548
| +48% | +$1.1M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.